Thiazoline and phthalimides derivatives as Mycobacterium tuberculosis MurB inhibitors: A molecular docking study

Vol 2, 2022 - 153243
Poster
Favoritar este trabajo
¿Cómo citar este artículo?
Resúmenes

The development of resistant strains of Mycobacterium tuberculosis (Mtb) is a big concern, which highlights the need of discovering new antibiotics1. Recent studies investigated molecular targets in earlier steps of peptidoglycan synthesis to discover new drugs for tuberculosis treatment2. These findings led us to select the enzyme UDP-N-acetylenolpyruvoylglucosamine reductase (MurB) due to its essential role in peptidoglycan synthesis and no eukaryote homologue2. Andres and coworkers discovered 4-thiazolidinones as MurB inhibitors at a micromolar level3. This way, we are proposing thiazoline and phthalimide derivatives as MurB inhibitors. Molecular docking studies were performed with MurB4 in complex with the proposed heterocycles with several aromatic substituents (electronic and steric effects) and their precursors, which resulted in more than 150 molecules. Interactions with key residues in MurB catalysis such as Arg176, Glu361 and Ser257 were observed, also theoretical Ki at low micromolar range. These results may guide the discovery of new antibiotics against Mtb.

¡Comparte tus ideas o preguntas con los autores!

¿Sabías que el mayor estímulo en el desarrollo científico y cultural es la curiosidad? ¡Deje sus preguntas o sugerencias al autor!

Inicia sesión para interactuar

¿Tiene alguna pregunta o sugerencia? ¡Comparte tus comentarios con los autores!

Instituciones
  • 1 Agreste Academic Centre, Universidade Federal de Pernambuco - UFPE
  • 2 Department of Fundamental Chemistry, Universidade Federal de Pernambuco - UFPE
Eje Temático
  • 1. Strategies in Drug Design
Palabras Clave
Drug Discovery
heterocyclic chemistry
Tuberculosis
antimicrobial agents